Impact of Acquired Broad Spectrum β-Lactamases on Susceptibility to Novel Combinations Made of β-Lactams (Aztreonam, Cefepime, Meropenem, and Imipenem) and Novel β-Lactamase Inhibitors in Escherichia coli and Pseudomonas aeruginosa
Antimicrobial Agents and Chemotherapy · 18.07.2023 · 67 (7)
DOI: 10.1128/aac.00339-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 18.07.2023. Verfasst von Christophe Le Terrier und 4 weiteren Autor:innen. Beteiligte Einrichtung: Emerging Antibiotic Resistance Unit, Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerla…. Hauptthemen laut MEDLINE: beta-Lactamase Inhibitors, beta-Lactams. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: University of Fribourg.
Abstract (Originalsprache)
The impact of broad-spectrum β-lactamases on the susceptibility to novel β-lactamase/β-lactamase inhibitor combinations was evaluated both in Pseudomonas aeruginosa and Escherichia coli using isogenic backgrounds. Cefepime-zidebactam displayed low MICs, mainly due to the significant intrinsic antibacterial activity of zidebactam.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Emerging Antibiotic Resistance Unit, Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland.
- Division of Intensive care unit, University hospitals of Geneva, Geneva, Switzerland.
- Swiss National Reference Center for Emerging Antibiotic Resistance, Fribourg, Switzerland.
- University of Lausanne and University hospital Center, Lausanne, Switzerland.
ORCID-Profile: Christophe Le Terrier, Patrice Nordmann, Laurent Poirel
Förderung
- University of Fribourg
Zitieren
APA
Le Terrier, C., Nordmann, P., Freret, C., Seigneur, M., & Poirel, L. (2023). Impact of Acquired Broad Spectrum β-Lactamases on Susceptibility to Novel Combinations Made of β-Lactams (Aztreonam, Cefepime, Meropenem, and Imipenem) and Novel β-Lactamase Inhibitors in Escherichia coli and Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy, 67(7). https://doi.org/10.1128/aac.00339-23
Vancouver
Le Terrier C, Nordmann P, Freret C, Seigneur M, Poirel L. Impact of Acquired Broad Spectrum β-Lactamases on Susceptibility to Novel Combinations Made of β-Lactams (Aztreonam, Cefepime, Meropenem, and Imipenem) and Novel β-Lactamase Inhibitors in Escherichia coli and Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 2023;67(7). doi:10.1128/aac.00339-23
BibTeX
@article{LeTerrier2023,
author = {Le Terrier, Christophe and Nordmann, Patrice and Freret, Charlotte and Seigneur, Marion and Poirel, Laurent},
title = {Impact of Acquired Broad Spectrum β-Lactamases on Susceptibility to Novel Combinations Made of β-Lactams (Aztreonam, Cefepime, Meropenem, and Imipenem) and Novel β-Lactamase Inhibitors in Escherichia coli and Pseudomonas aeruginosa},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2023},
volume = {67},
number = {7},
doi = {10.1128/aac.00339-23}
}
EUVIMED